RadioLigand Therapy with [(177)Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France

Salivary gland cancers are rare tumors comprising a large group of heterogeneous tumors with variable prognosis. Their therapeutic management at a metastatic stage is challenging due to the lack of therapeutic lines and the toxicity of treatments. [(177)Lu]Lu-PSMA-617 (prostate-specific membrane ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Terroir, Marie, Lamesa, Chloé, Krim, Mehdi, Vija, Lavinia, Texier, Jean-Sébastien, Cassou-Mounat, Thibaut, Delord, Jean-Pierre, Vallot, Delphine, Courbon, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222097/
https://www.ncbi.nlm.nih.gov/pubmed/37242537
http://dx.doi.org/10.3390/ph16050754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222097/
https://www.ncbi.nlm.nih.gov/pubmed/37242537
http://dx.doi.org/10.3390/ph16050754

Ejemplares similares